Global Rabies Immune Globulin (Equine) Market Research Report 2026(Status and Outlook)
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
The global Rabies Immune Globulin (Equine) market size was estimated at USD 1281.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rabies Immune Globulin (Equine) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rabies Immune Globulin (Equine) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rabies Immune Globulin (Equine) market.
Global Rabies Immune Globulin (Equine) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Market Segmentation (by Type)
1500IU
1000IU
400IU
Others
Market Segmentation (by Application)
Clinic
Hospital
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rabies Immune Globulin (Equine) Market
Overview of the regional outlook of the Rabies Immune Globulin (Equine) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rabies Immune Globulin (Equine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rabies Immune Globulin (Equine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Rabies Immune Globulin (Equine) market size was estimated at USD 1281.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Rabies Immune Globulin (Equine) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Rabies Immune Globulin (Equine) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Rabies Immune Globulin (Equine) market.
Global Rabies Immune Globulin (Equine) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Market Segmentation (by Type)
1500IU
1000IU
400IU
Others
Market Segmentation (by Application)
Clinic
Hospital
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rabies Immune Globulin (Equine) Market
Overview of the regional outlook of the Rabies Immune Globulin (Equine) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rabies Immune Globulin (Equine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Rabies Immune Globulin (Equine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Rabies Immune Globulin (Equine)
1.2 Key Market Segments
1.2.1 Rabies Immune Globulin (Equine) Segment by Type
1.2.2 Rabies Immune Globulin (Equine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RABIES IMMUNE GLOBULIN (EQUINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rabies Immune Globulin (Equine) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Rabies Immune Globulin (Equine) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RABIES IMMUNE GLOBULIN (EQUINE) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rabies Immune Globulin (Equine) Product Life Cycle
3.3 Global Rabies Immune Globulin (Equine) Sales by Manufacturers (2020-2025)
3.4 Global Rabies Immune Globulin (Equine) Revenue Market Share by Manufacturers (2020-2025)
3.5 Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Rabies Immune Globulin (Equine) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Rabies Immune Globulin (Equine) Market Competitive Situation and Trends
3.8.1 Rabies Immune Globulin (Equine) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Rabies Immune Globulin (Equine) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RABIES IMMUNE GLOBULIN (EQUINE) INDUSTRY CHAIN ANALYSIS
4.1 Rabies Immune Globulin (Equine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RABIES IMMUNE GLOBULIN (EQUINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rabies Immune Globulin (Equine) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Rabies Immune Globulin (Equine) Market
5.7 ESG Ratings of Leading Companies
6 RABIES IMMUNE GLOBULIN (EQUINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2020-2025)
6.3 Global Rabies Immune Globulin (Equine) Market Size by Type (2020-2025)
6.4 Global Rabies Immune Globulin (Equine) Price by Type (2020-2025)
7 RABIES IMMUNE GLOBULIN (EQUINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rabies Immune Globulin (Equine) Market Sales by Application (2020-2025)
7.3 Global Rabies Immune Globulin (Equine) Market Size (M USD) by Application (2020-2025)
7.4 Global Rabies Immune Globulin (Equine) Sales Growth Rate by Application (2020-2025)
8 RABIES IMMUNE GLOBULIN (EQUINE) MARKET SALES BY REGION
8.1 Global Rabies Immune Globulin (Equine) Sales by Region
8.1.1 Global Rabies Immune Globulin (Equine) Sales by Region
8.1.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Region
8.2 Global Rabies Immune Globulin (Equine) Market Size by Region
8.2.1 Global Rabies Immune Globulin (Equine) Market Size by Region
8.2.2 Global Rabies Immune Globulin (Equine) Market Size by Region
8.3 North America
8.3.1 North America Rabies Immune Globulin (Equine) Sales by Country
8.3.2 North America Rabies Immune Globulin (Equine) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Rabies Immune Globulin (Equine) Sales by Country
8.4.2 Europe Rabies Immune Globulin (Equine) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Rabies Immune Globulin (Equine) Sales by Region
8.5.2 Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Rabies Immune Globulin (Equine) Sales by Country
8.6.2 South America Rabies Immune Globulin (Equine) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Rabies Immune Globulin (Equine) Sales by Region
8.7.2 Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RABIES IMMUNE GLOBULIN (EQUINE) MARKET PRODUCTION BY REGION
9.1 Global Production of Rabies Immune Globulin (Equine) by Region(2020-2025)
9.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2020-2025)
9.3 Global Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Rabies Immune Globulin (Equine) Production
9.4.1 North America Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.4.2 North America Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Rabies Immune Globulin (Equine) Production
9.5.1 Europe Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.5.2 Europe Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Rabies Immune Globulin (Equine) Production (2020-2025)
9.6.1 Japan Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.6.2 Japan Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Rabies Immune Globulin (Equine) Production (2020-2025)
9.7.1 China Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.7.2 China Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Grifols
10.1.1 Grifols Basic Information
10.1.2 Grifols Rabies Immune Globulin (Equine) Product Overview
10.1.3 Grifols Rabies Immune Globulin (Equine) Product Market Performance
10.1.4 Grifols Business Overview
10.1.5 Grifols SWOT Analysis
10.1.6 Grifols Recent Developments
10.2 Serum China
10.2.1 Serum China Basic Information
10.2.2 Serum China Rabies Immune Globulin (Equine) Product Overview
10.2.3 Serum China Rabies Immune Globulin (Equine) Product Market Performance
10.2.4 Serum China Business Overview
10.2.5 Serum China SWOT Analysis
10.2.6 Serum China Recent Developments
10.3 Premium Serums
10.3.1 Premium Serums Basic Information
10.3.2 Premium Serums Rabies Immune Globulin (Equine) Product Overview
10.3.3 Premium Serums Rabies Immune Globulin (Equine) Product Market Performance
10.3.4 Premium Serums Business Overview
10.3.5 Premium Serums SWOT Analysis
10.3.6 Premium Serums Recent Developments
10.4 Intas
10.4.1 Intas Basic Information
10.4.2 Intas Rabies Immune Globulin (Equine) Product Overview
10.4.3 Intas Rabies Immune Globulin (Equine) Product Market Performance
10.4.4 Intas Business Overview
10.4.5 Intas Recent Developments
10.5 Aventis Pasteur India
10.5.1 Aventis Pasteur India Basic Information
10.5.2 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Overview
10.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Market Performance
10.5.4 Aventis Pasteur India Business Overview
10.5.5 Aventis Pasteur India Recent Developments
10.6 Cadila Pharmaceuticals
10.6.1 Cadila Pharmaceuticals Basic Information
10.6.2 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Overview
10.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Market Performance
10.6.4 Cadila Pharmaceuticals Business Overview
10.6.5 Cadila Pharmaceuticals Recent Developments
10.7 Zydus Takeda Healthcare
10.7.1 Zydus Takeda Healthcare Basic Information
10.7.2 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Overview
10.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Market Performance
10.7.4 Zydus Takeda Healthcare Business Overview
10.7.5 Zydus Takeda Healthcare Recent Developments
10.8 Bharat Serums And Vaccines
10.8.1 Bharat Serums And Vaccines Basic Information
10.8.2 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Overview
10.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Market Performance
10.8.4 Bharat Serums And Vaccines Business Overview
10.8.5 Bharat Serums And Vaccines Recent Developments
10.9 GlaxoSmithKline GmbH
10.9.1 GlaxoSmithKline GmbH Basic Information
10.9.2 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Overview
10.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Market Performance
10.9.4 GlaxoSmithKline GmbH Business Overview
10.9.5 GlaxoSmithKline GmbH Recent Developments
10.10 VINS Bioproducts
10.10.1 VINS Bioproducts Basic Information
10.10.2 VINS Bioproducts Rabies Immune Globulin (Equine) Product Overview
10.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Product Market Performance
10.10.4 VINS Bioproducts Business Overview
10.10.5 VINS Bioproducts Recent Developments
10.11 CSL Behring
10.11.1 CSL Behring Basic Information
10.11.2 CSL Behring Rabies Immune Globulin (Equine) Product Overview
10.11.3 CSL Behring Rabies Immune Globulin (Equine) Product Market Performance
10.11.4 CSL Behring Business Overview
10.11.5 CSL Behring Recent Developments
11 RABIES IMMUNE GLOBULIN (EQUINE) MARKET FORECAST BY REGION
11.1 Global Rabies Immune Globulin (Equine) Market Size Forecast
11.2 Global Rabies Immune Globulin (Equine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Rabies Immune Globulin (Equine) Market Size Forecast by Country
11.2.3 Asia Pacific Rabies Immune Globulin (Equine) Market Size Forecast by Region
11.2.4 South America Rabies Immune Globulin (Equine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Rabies Immune Globulin (Equine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Rabies Immune Globulin (Equine) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Rabies Immune Globulin (Equine) by Type (2026-2035)
12.1.2 Global Rabies Immune Globulin (Equine) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Rabies Immune Globulin (Equine) by Type (2026-2035)
12.2 Global Rabies Immune Globulin (Equine) Market Forecast by Application (2026-2035)
12.2.1 Global Rabies Immune Globulin (Equine) Sales (K MT) Forecast by Application
12.2.2 Global Rabies Immune Globulin (Equine) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Rabies Immune Globulin (Equine)
1.2 Key Market Segments
1.2.1 Rabies Immune Globulin (Equine) Segment by Type
1.2.2 Rabies Immune Globulin (Equine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RABIES IMMUNE GLOBULIN (EQUINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rabies Immune Globulin (Equine) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Rabies Immune Globulin (Equine) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RABIES IMMUNE GLOBULIN (EQUINE) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Rabies Immune Globulin (Equine) Product Life Cycle
3.3 Global Rabies Immune Globulin (Equine) Sales by Manufacturers (2020-2025)
3.4 Global Rabies Immune Globulin (Equine) Revenue Market Share by Manufacturers (2020-2025)
3.5 Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Rabies Immune Globulin (Equine) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Rabies Immune Globulin (Equine) Market Competitive Situation and Trends
3.8.1 Rabies Immune Globulin (Equine) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Rabies Immune Globulin (Equine) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RABIES IMMUNE GLOBULIN (EQUINE) INDUSTRY CHAIN ANALYSIS
4.1 Rabies Immune Globulin (Equine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RABIES IMMUNE GLOBULIN (EQUINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Rabies Immune Globulin (Equine) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Rabies Immune Globulin (Equine) Market
5.7 ESG Ratings of Leading Companies
6 RABIES IMMUNE GLOBULIN (EQUINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2020-2025)
6.3 Global Rabies Immune Globulin (Equine) Market Size by Type (2020-2025)
6.4 Global Rabies Immune Globulin (Equine) Price by Type (2020-2025)
7 RABIES IMMUNE GLOBULIN (EQUINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rabies Immune Globulin (Equine) Market Sales by Application (2020-2025)
7.3 Global Rabies Immune Globulin (Equine) Market Size (M USD) by Application (2020-2025)
7.4 Global Rabies Immune Globulin (Equine) Sales Growth Rate by Application (2020-2025)
8 RABIES IMMUNE GLOBULIN (EQUINE) MARKET SALES BY REGION
8.1 Global Rabies Immune Globulin (Equine) Sales by Region
8.1.1 Global Rabies Immune Globulin (Equine) Sales by Region
8.1.2 Global Rabies Immune Globulin (Equine) Sales Market Share by Region
8.2 Global Rabies Immune Globulin (Equine) Market Size by Region
8.2.1 Global Rabies Immune Globulin (Equine) Market Size by Region
8.2.2 Global Rabies Immune Globulin (Equine) Market Size by Region
8.3 North America
8.3.1 North America Rabies Immune Globulin (Equine) Sales by Country
8.3.2 North America Rabies Immune Globulin (Equine) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Rabies Immune Globulin (Equine) Sales by Country
8.4.2 Europe Rabies Immune Globulin (Equine) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Rabies Immune Globulin (Equine) Sales by Region
8.5.2 Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Rabies Immune Globulin (Equine) Sales by Country
8.6.2 South America Rabies Immune Globulin (Equine) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Rabies Immune Globulin (Equine) Sales by Region
8.7.2 Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RABIES IMMUNE GLOBULIN (EQUINE) MARKET PRODUCTION BY REGION
9.1 Global Production of Rabies Immune Globulin (Equine) by Region(2020-2025)
9.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2020-2025)
9.3 Global Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Rabies Immune Globulin (Equine) Production
9.4.1 North America Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.4.2 North America Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Rabies Immune Globulin (Equine) Production
9.5.1 Europe Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.5.2 Europe Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Rabies Immune Globulin (Equine) Production (2020-2025)
9.6.1 Japan Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.6.2 Japan Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Rabies Immune Globulin (Equine) Production (2020-2025)
9.7.1 China Rabies Immune Globulin (Equine) Production Growth Rate (2020-2025)
9.7.2 China Rabies Immune Globulin (Equine) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Grifols
10.1.1 Grifols Basic Information
10.1.2 Grifols Rabies Immune Globulin (Equine) Product Overview
10.1.3 Grifols Rabies Immune Globulin (Equine) Product Market Performance
10.1.4 Grifols Business Overview
10.1.5 Grifols SWOT Analysis
10.1.6 Grifols Recent Developments
10.2 Serum China
10.2.1 Serum China Basic Information
10.2.2 Serum China Rabies Immune Globulin (Equine) Product Overview
10.2.3 Serum China Rabies Immune Globulin (Equine) Product Market Performance
10.2.4 Serum China Business Overview
10.2.5 Serum China SWOT Analysis
10.2.6 Serum China Recent Developments
10.3 Premium Serums
10.3.1 Premium Serums Basic Information
10.3.2 Premium Serums Rabies Immune Globulin (Equine) Product Overview
10.3.3 Premium Serums Rabies Immune Globulin (Equine) Product Market Performance
10.3.4 Premium Serums Business Overview
10.3.5 Premium Serums SWOT Analysis
10.3.6 Premium Serums Recent Developments
10.4 Intas
10.4.1 Intas Basic Information
10.4.2 Intas Rabies Immune Globulin (Equine) Product Overview
10.4.3 Intas Rabies Immune Globulin (Equine) Product Market Performance
10.4.4 Intas Business Overview
10.4.5 Intas Recent Developments
10.5 Aventis Pasteur India
10.5.1 Aventis Pasteur India Basic Information
10.5.2 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Overview
10.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Market Performance
10.5.4 Aventis Pasteur India Business Overview
10.5.5 Aventis Pasteur India Recent Developments
10.6 Cadila Pharmaceuticals
10.6.1 Cadila Pharmaceuticals Basic Information
10.6.2 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Overview
10.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Market Performance
10.6.4 Cadila Pharmaceuticals Business Overview
10.6.5 Cadila Pharmaceuticals Recent Developments
10.7 Zydus Takeda Healthcare
10.7.1 Zydus Takeda Healthcare Basic Information
10.7.2 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Overview
10.7.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Market Performance
10.7.4 Zydus Takeda Healthcare Business Overview
10.7.5 Zydus Takeda Healthcare Recent Developments
10.8 Bharat Serums And Vaccines
10.8.1 Bharat Serums And Vaccines Basic Information
10.8.2 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Overview
10.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Market Performance
10.8.4 Bharat Serums And Vaccines Business Overview
10.8.5 Bharat Serums And Vaccines Recent Developments
10.9 GlaxoSmithKline GmbH
10.9.1 GlaxoSmithKline GmbH Basic Information
10.9.2 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Overview
10.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Market Performance
10.9.4 GlaxoSmithKline GmbH Business Overview
10.9.5 GlaxoSmithKline GmbH Recent Developments
10.10 VINS Bioproducts
10.10.1 VINS Bioproducts Basic Information
10.10.2 VINS Bioproducts Rabies Immune Globulin (Equine) Product Overview
10.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Product Market Performance
10.10.4 VINS Bioproducts Business Overview
10.10.5 VINS Bioproducts Recent Developments
10.11 CSL Behring
10.11.1 CSL Behring Basic Information
10.11.2 CSL Behring Rabies Immune Globulin (Equine) Product Overview
10.11.3 CSL Behring Rabies Immune Globulin (Equine) Product Market Performance
10.11.4 CSL Behring Business Overview
10.11.5 CSL Behring Recent Developments
11 RABIES IMMUNE GLOBULIN (EQUINE) MARKET FORECAST BY REGION
11.1 Global Rabies Immune Globulin (Equine) Market Size Forecast
11.2 Global Rabies Immune Globulin (Equine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Rabies Immune Globulin (Equine) Market Size Forecast by Country
11.2.3 Asia Pacific Rabies Immune Globulin (Equine) Market Size Forecast by Region
11.2.4 South America Rabies Immune Globulin (Equine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Rabies Immune Globulin (Equine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Rabies Immune Globulin (Equine) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Rabies Immune Globulin (Equine) by Type (2026-2035)
12.1.2 Global Rabies Immune Globulin (Equine) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Rabies Immune Globulin (Equine) by Type (2026-2035)
12.2 Global Rabies Immune Globulin (Equine) Market Forecast by Application (2026-2035)
12.2.1 Global Rabies Immune Globulin (Equine) Sales (K MT) Forecast by Application
12.2.2 Global Rabies Immune Globulin (Equine) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Rabies Immune Globulin (Equine) Market Size by Type (M USD)
Table 4. Global Rabies Immune Globulin (Equine) Market Size by Application
Table 5. Rabies Immune Globulin (Equine) Market Size Comparison by Region (M USD)
Table 6. Global Rabies Immune Globulin (Equine) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Rabies Immune Globulin (Equine) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2025)
Table 11. Global Market Rabies Immune Globulin (Equine) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Rabies Immune Globulin (Equine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rabies Immune Globulin (Equine) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Rabies Immune Globulin (Equine) Sales by Type (K MT)
Table 27. Global Rabies Immune Globulin (Equine) Market Size by Type (M USD)
Table 28. Global Rabies Immune Globulin (Equine) Sales (K MT) by Type (2020-2025)
Table 29. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2020-2025)
Table 30. Global Rabies Immune Globulin (Equine) Market Size (M USD) by Type (2020-2025)
Table 31. Global Rabies Immune Globulin (Equine) Market Share by Type (2020-2025)
Table 32. Global Rabies Immune Globulin (Equine) Price (USD/KG) by Type (2020-2025)
Table 33. Global Rabies Immune Globulin (Equine) Sales (K MT) by Application
Table 34. Global Rabies Immune Globulin (Equine) Market Size by Application
Table 35. Global Rabies Immune Globulin (Equine) Sales by Application (2020-2025) & (K MT)
Table 36. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2020-2025)
Table 37. Global Rabies Immune Globulin (Equine) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Rabies Immune Globulin (Equine) Market Share by Application (2020-2025)
Table 39. Global Rabies Immune Globulin (Equine) Sales Growth Rate by Application (2020-2025)
Table 40. Global Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K MT)
Table 41. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2020-2025)
Table 42. Global Rabies Immune Globulin (Equine) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Rabies Immune Globulin (Equine) Market Size by Region (2020-2025)
Table 44. North America Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K MT)
Table 45. North America Rabies Immune Globulin (Equine) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Rabies Immune Globulin (Equine) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K MT)
Table 51. South America Rabies Immune Globulin (Equine) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Rabies Immune Globulin (Equine) Production (K MT) by Region(2020-2025)
Table 55. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2020-2025)
Table 57. Global Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Grifols Basic Information
Table 63. Grifols Rabies Immune Globulin (Equine) Product Overview
Table 64. Grifols Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Grifols Business Overview
Table 66. Grifols SWOT Analysis
Table 67. Grifols Recent Developments
Table 68. Serum China Basic Information
Table 69. Serum China Rabies Immune Globulin (Equine) Product Overview
Table 70. Serum China Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Serum China Business Overview
Table 72. Serum China SWOT Analysis
Table 73. Serum China Recent Developments
Table 74. Premium Serums Basic Information
Table 75. Premium Serums Rabies Immune Globulin (Equine) Product Overview
Table 76. Premium Serums Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Premium Serums Business Overview
Table 78. Premium Serums SWOT Analysis
Table 79. Premium Serums Recent Developments
Table 80. Intas Basic Information
Table 81. Intas Rabies Immune Globulin (Equine) Product Overview
Table 82. Intas Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Intas Business Overview
Table 84. Intas Recent Developments
Table 85. Aventis Pasteur India Basic Information
Table 86. Aventis Pasteur India Rabies Immune Globulin (Equine) Product Overview
Table 87. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Aventis Pasteur India Business Overview
Table 89. Aventis Pasteur India Recent Developments
Table 90. Cadila Pharmaceuticals Basic Information
Table 91. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Overview
Table 92. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Cadila Pharmaceuticals Business Overview
Table 94. Cadila Pharmaceuticals Recent Developments
Table 95. Zydus Takeda Healthcare Basic Information
Table 96. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Overview
Table 97. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Zydus Takeda Healthcare Business Overview
Table 99. Zydus Takeda Healthcare Recent Developments
Table 100. Bharat Serums And Vaccines Basic Information
Table 101. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Overview
Table 102. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bharat Serums And Vaccines Business Overview
Table 104. Bharat Serums And Vaccines Recent Developments
Table 105. GlaxoSmithKline GmbH Basic Information
Table 106. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Overview
Table 107. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline GmbH Business Overview
Table 109. GlaxoSmithKline GmbH Recent Developments
Table 110. VINS Bioproducts Basic Information
Table 111. VINS Bioproducts Rabies Immune Globulin (Equine) Product Overview
Table 112. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. VINS Bioproducts Business Overview
Table 114. VINS Bioproducts Recent Developments
Table 115. CSL Behring Basic Information
Table 116. CSL Behring Rabies Immune Globulin (Equine) Product Overview
Table 117. CSL Behring Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. CSL Behring Business Overview
Table 119. CSL Behring Recent Developments
Table 120. Global Rabies Immune Globulin (Equine) Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Rabies Immune Globulin (Equine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Rabies Immune Globulin (Equine) Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Rabies Immune Globulin (Equine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Rabies Immune Globulin (Equine) Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Rabies Immune Globulin (Equine) Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Rabies Immune Globulin (Equine) Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Rabies Immune Globulin (Equine) Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Rabies Immune Globulin (Equine) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Rabies Immune Globulin (Equine) Market Size by Type (M USD)
Table 4. Global Rabies Immune Globulin (Equine) Market Size by Application
Table 5. Rabies Immune Globulin (Equine) Market Size Comparison by Region (M USD)
Table 6. Global Rabies Immune Globulin (Equine) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Rabies Immune Globulin (Equine) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Equine) as of 2025)
Table 11. Global Market Rabies Immune Globulin (Equine) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Rabies Immune Globulin (Equine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rabies Immune Globulin (Equine) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Rabies Immune Globulin (Equine) Sales by Type (K MT)
Table 27. Global Rabies Immune Globulin (Equine) Market Size by Type (M USD)
Table 28. Global Rabies Immune Globulin (Equine) Sales (K MT) by Type (2020-2025)
Table 29. Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2020-2025)
Table 30. Global Rabies Immune Globulin (Equine) Market Size (M USD) by Type (2020-2025)
Table 31. Global Rabies Immune Globulin (Equine) Market Share by Type (2020-2025)
Table 32. Global Rabies Immune Globulin (Equine) Price (USD/KG) by Type (2020-2025)
Table 33. Global Rabies Immune Globulin (Equine) Sales (K MT) by Application
Table 34. Global Rabies Immune Globulin (Equine) Market Size by Application
Table 35. Global Rabies Immune Globulin (Equine) Sales by Application (2020-2025) & (K MT)
Table 36. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2020-2025)
Table 37. Global Rabies Immune Globulin (Equine) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Rabies Immune Globulin (Equine) Market Share by Application (2020-2025)
Table 39. Global Rabies Immune Globulin (Equine) Sales Growth Rate by Application (2020-2025)
Table 40. Global Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K MT)
Table 41. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2020-2025)
Table 42. Global Rabies Immune Globulin (Equine) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Rabies Immune Globulin (Equine) Market Size by Region (2020-2025)
Table 44. North America Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K MT)
Table 45. North America Rabies Immune Globulin (Equine) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K MT)
Table 47. Europe Rabies Immune Globulin (Equine) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Rabies Immune Globulin (Equine) Sales by Country (2020-2025) & (K MT)
Table 51. South America Rabies Immune Globulin (Equine) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Rabies Immune Globulin (Equine) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Rabies Immune Globulin (Equine) Production (K MT) by Region(2020-2025)
Table 55. Global Rabies Immune Globulin (Equine) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Rabies Immune Globulin (Equine) Revenue Market Share by Region (2020-2025)
Table 57. Global Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Rabies Immune Globulin (Equine) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Grifols Basic Information
Table 63. Grifols Rabies Immune Globulin (Equine) Product Overview
Table 64. Grifols Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Grifols Business Overview
Table 66. Grifols SWOT Analysis
Table 67. Grifols Recent Developments
Table 68. Serum China Basic Information
Table 69. Serum China Rabies Immune Globulin (Equine) Product Overview
Table 70. Serum China Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Serum China Business Overview
Table 72. Serum China SWOT Analysis
Table 73. Serum China Recent Developments
Table 74. Premium Serums Basic Information
Table 75. Premium Serums Rabies Immune Globulin (Equine) Product Overview
Table 76. Premium Serums Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Premium Serums Business Overview
Table 78. Premium Serums SWOT Analysis
Table 79. Premium Serums Recent Developments
Table 80. Intas Basic Information
Table 81. Intas Rabies Immune Globulin (Equine) Product Overview
Table 82. Intas Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Intas Business Overview
Table 84. Intas Recent Developments
Table 85. Aventis Pasteur India Basic Information
Table 86. Aventis Pasteur India Rabies Immune Globulin (Equine) Product Overview
Table 87. Aventis Pasteur India Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Aventis Pasteur India Business Overview
Table 89. Aventis Pasteur India Recent Developments
Table 90. Cadila Pharmaceuticals Basic Information
Table 91. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Overview
Table 92. Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Cadila Pharmaceuticals Business Overview
Table 94. Cadila Pharmaceuticals Recent Developments
Table 95. Zydus Takeda Healthcare Basic Information
Table 96. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Overview
Table 97. Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Zydus Takeda Healthcare Business Overview
Table 99. Zydus Takeda Healthcare Recent Developments
Table 100. Bharat Serums And Vaccines Basic Information
Table 101. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Overview
Table 102. Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bharat Serums And Vaccines Business Overview
Table 104. Bharat Serums And Vaccines Recent Developments
Table 105. GlaxoSmithKline GmbH Basic Information
Table 106. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Overview
Table 107. GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline GmbH Business Overview
Table 109. GlaxoSmithKline GmbH Recent Developments
Table 110. VINS Bioproducts Basic Information
Table 111. VINS Bioproducts Rabies Immune Globulin (Equine) Product Overview
Table 112. VINS Bioproducts Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. VINS Bioproducts Business Overview
Table 114. VINS Bioproducts Recent Developments
Table 115. CSL Behring Basic Information
Table 116. CSL Behring Rabies Immune Globulin (Equine) Product Overview
Table 117. CSL Behring Rabies Immune Globulin (Equine) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. CSL Behring Business Overview
Table 119. CSL Behring Recent Developments
Table 120. Global Rabies Immune Globulin (Equine) Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Rabies Immune Globulin (Equine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Rabies Immune Globulin (Equine) Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Rabies Immune Globulin (Equine) Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Rabies Immune Globulin (Equine) Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Rabies Immune Globulin (Equine) Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Rabies Immune Globulin (Equine) Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Rabies Immune Globulin (Equine) Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Rabies Immune Globulin (Equine) Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Rabies Immune Globulin (Equine) Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Rabies Immune Globulin (Equine) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Rabies Immune Globulin (Equine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rabies Immune Globulin (Equine) Market Size (M USD), 2025-2035
Figure 5. Global Rabies Immune Globulin (Equine) Market Size (M USD) (2020-2035)
Figure 6. Global Rabies Immune Globulin (Equine) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rabies Immune Globulin (Equine) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Rabies Immune Globulin (Equine) Product Life Cycle
Figure 13. Rabies Immune Globulin (Equine) Sales Share by Manufacturers in 2025
Figure 14. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers in 2025
Figure 15. Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Rabies Immune Globulin (Equine) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rabies Immune Globulin (Equine) Revenue in 2025
Figure 18. Industry Chain Map of Rabies Immune Globulin (Equine)
Figure 19. Global Rabies Immune Globulin (Equine) Market PEST Analysis
Figure 20. Global Rabies Immune Globulin (Equine) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Rabies Immune Globulin (Equine) Market Share by Type
Figure 27. Sales Market Share of Rabies Immune Globulin (Equine) by Type (2020-2025)
Figure 28. Sales Market Share of Rabies Immune Globulin (Equine) by Type in 2025
Figure 29. Market Share of Rabies Immune Globulin (Equine) by Type (2020-2025)
Figure 30. Market Share of Rabies Immune Globulin (Equine) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Rabies Immune Globulin (Equine) Market Share by Application
Figure 33. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2020-2025)
Figure 34. Global Rabies Immune Globulin (Equine) Sales Market Share by Application in 2025
Figure 35. Global Rabies Immune Globulin (Equine) Market Share by Application (2020-2025)
Figure 36. Global Rabies Immune Globulin (Equine) Market Share by Application in 2025
Figure 37. Global Rabies Immune Globulin (Equine) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2020-2025)
Figure 39. Global Rabies Immune Globulin (Equine) Market Size by Region (2020-2025)
Figure 40. North America Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Rabies Immune Globulin (Equine) Sales Market Share by Country in 2024
Figure 43. North America Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Rabies Immune Globulin (Equine) Market Size by Country in 2024
Figure 45. U.S. Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Rabies Immune Globulin (Equine) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Rabies Immune Globulin (Equine) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Rabies Immune Globulin (Equine) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Rabies Immune Globulin (Equine) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country in 2024
Figure 53. Europe Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Rabies Immune Globulin (Equine) Market Size by Country in 2024
Figure 55. Germany Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Rabies Immune Globulin (Equine) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Rabies Immune Globulin (Equine) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region in 2024
Figure 68. China Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Rabies Immune Globulin (Equine) Sales and Growth Rate (K MT)
Figure 79. South America Rabies Immune Globulin (Equine) Sales Market Share by Country in 2024
Figure 80. South America Rabies Immune Globulin (Equine) Market Size and Growth Rate (M USD)
Figure 81. South America Rabies Immune Globulin (Equine) Market Size by Country in 2024
Figure 82. Brazil Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Rabies Immune Globulin (Equine) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Rabies Immune Globulin (Equine) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Rabies Immune Globulin (Equine) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Region in 2024
Figure 92. Saudi Arabia Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Rabies Immune Globulin (Equine) Production Market Share by Region (2020-2025)
Figure 103. North America Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Rabies Immune Globulin (Equine) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Rabies Immune Globulin (Equine) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Rabies Immune Globulin (Equine) Market Share Forecast by Type (2026-2035)
Figure 111. Global Rabies Immune Globulin (Equine) Sales Forecast by Application (2026-2035)
Figure 112. Global Rabies Immune Globulin (Equine) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Rabies Immune Globulin (Equine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rabies Immune Globulin (Equine) Market Size (M USD), 2025-2035
Figure 5. Global Rabies Immune Globulin (Equine) Market Size (M USD) (2020-2035)
Figure 6. Global Rabies Immune Globulin (Equine) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rabies Immune Globulin (Equine) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Rabies Immune Globulin (Equine) Product Life Cycle
Figure 13. Rabies Immune Globulin (Equine) Sales Share by Manufacturers in 2025
Figure 14. Global Rabies Immune Globulin (Equine) Revenue Share by Manufacturers in 2025
Figure 15. Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Rabies Immune Globulin (Equine) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rabies Immune Globulin (Equine) Revenue in 2025
Figure 18. Industry Chain Map of Rabies Immune Globulin (Equine)
Figure 19. Global Rabies Immune Globulin (Equine) Market PEST Analysis
Figure 20. Global Rabies Immune Globulin (Equine) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Rabies Immune Globulin (Equine) Market Share by Type
Figure 27. Sales Market Share of Rabies Immune Globulin (Equine) by Type (2020-2025)
Figure 28. Sales Market Share of Rabies Immune Globulin (Equine) by Type in 2025
Figure 29. Market Share of Rabies Immune Globulin (Equine) by Type (2020-2025)
Figure 30. Market Share of Rabies Immune Globulin (Equine) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Rabies Immune Globulin (Equine) Market Share by Application
Figure 33. Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2020-2025)
Figure 34. Global Rabies Immune Globulin (Equine) Sales Market Share by Application in 2025
Figure 35. Global Rabies Immune Globulin (Equine) Market Share by Application (2020-2025)
Figure 36. Global Rabies Immune Globulin (Equine) Market Share by Application in 2025
Figure 37. Global Rabies Immune Globulin (Equine) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Rabies Immune Globulin (Equine) Sales Market Share by Region (2020-2025)
Figure 39. Global Rabies Immune Globulin (Equine) Market Size by Region (2020-2025)
Figure 40. North America Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Rabies Immune Globulin (Equine) Sales Market Share by Country in 2024
Figure 43. North America Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Rabies Immune Globulin (Equine) Market Size by Country in 2024
Figure 45. U.S. Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Rabies Immune Globulin (Equine) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Rabies Immune Globulin (Equine) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Rabies Immune Globulin (Equine) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Rabies Immune Globulin (Equine) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Rabies Immune Globulin (Equine) Sales Market Share by Country in 2024
Figure 53. Europe Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Rabies Immune Globulin (Equine) Market Size by Country in 2024
Figure 55. Germany Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Rabies Immune Globulin (Equine) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Rabies Immune Globulin (Equine) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Rabies Immune Globulin (Equine) Market Size by Region in 2024
Figure 68. China Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Rabies Immune Globulin (Equine) Sales and Growth Rate (K MT)
Figure 79. South America Rabies Immune Globulin (Equine) Sales Market Share by Country in 2024
Figure 80. South America Rabies Immune Globulin (Equine) Market Size and Growth Rate (M USD)
Figure 81. South America Rabies Immune Globulin (Equine) Market Size by Country in 2024
Figure 82. Brazil Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Rabies Immune Globulin (Equine) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Rabies Immune Globulin (Equine) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Rabies Immune Globulin (Equine) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Region in 2024
Figure 92. Saudi Arabia Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Rabies Immune Globulin (Equine) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Rabies Immune Globulin (Equine) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Rabies Immune Globulin (Equine) Production Market Share by Region (2020-2025)
Figure 103. North America Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Rabies Immune Globulin (Equine) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Rabies Immune Globulin (Equine) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Rabies Immune Globulin (Equine) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Rabies Immune Globulin (Equine) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Rabies Immune Globulin (Equine) Market Share Forecast by Type (2026-2035)
Figure 111. Global Rabies Immune Globulin (Equine) Sales Forecast by Application (2026-2035)
Figure 112. Global Rabies Immune Globulin (Equine) Market Share Forecast by Application (2026-2035)
